These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 17251466)

  • 1. Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis.
    Qi X; Lewin AS; Sun L; Hauswirth WW; Guy J
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):681-91. PubMed ID: 17251466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy.
    Qi X; Sun L; Lewin AS; Hauswirth WW; Guy J
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5360-70. PubMed ID: 18055782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optic nerve degeneration in experimental autoimmune encephalomyelitis.
    Guy J
    Ophthalmic Res; 2008; 40(3-4):212-6. PubMed ID: 18421242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optic neuropathy induced by reductions in mitochondrial superoxide dismutase.
    Qi X; Lewin AS; Hauswirth WW; Guy J
    Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1088-96. PubMed ID: 12601034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal ganglion cell damage induced by spontaneous autoimmune optic neuritis in MOG-specific TCR transgenic mice.
    Guan Y; Shindler KS; Tabuena P; Rostami AM
    J Neuroimmunol; 2006 Sep; 178(1-2):40-8. PubMed ID: 16828169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of manganese superoxide dismutase, but not of Cu/Zn-SOD, in experimental optic neuritis.
    Qi X; Guy J; Nick H; Valentine J; Rao N
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1203-12. PubMed ID: 9152240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spermidine alleviates severity of murine experimental autoimmune encephalomyelitis.
    Guo X; Harada C; Namekata K; Kimura A; Mitamura Y; Yoshida H; Matsumoto Y; Harada T
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2696-703. PubMed ID: 21228387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversals of blood-brain barrier disruption by catalase: a serial magnetic resonance imaging study of experimental optic neuritis.
    Guy J; McGorray S; Fitzsimmons J; Beck B; Mancuso A; Rao NA; Hamed L
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3456-65. PubMed ID: 8056521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
    Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
    Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual gene therapy with extracellular superoxide dismutase and catalase attenuates experimental optic neuritis.
    Qi X; Hauswirth WW; Guy J
    Mol Vis; 2007 Jan; 13():1-11. PubMed ID: 17242675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antioxidant gene therapy on retinal neurons and oxidative stress in a model of retinal ischemia/reperfusion.
    Liu Y; Tang L; Chen B
    Free Radic Biol Med; 2012 Mar; 52(5):909-15. PubMed ID: 22240151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.
    Adamus G; Brown L; Andrew S; Meza-Romero R; Burrows GG; Vandenbark AA
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):406-12. PubMed ID: 22167100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mutant human ND4 subunit of complex I induces optic neuropathy in the mouse.
    Qi X; Sun L; Lewin AS; Hauswirth WW; Guy J
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):1-10. PubMed ID: 17197509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral gene therapy with catalase suppresses experimental optic neuritis.
    Guy J; Qi X; Wang H; Hauswirth WW
    Arch Ophthalmol; 1999 Nov; 117(11):1533-9. PubMed ID: 10565523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axonal loss and myelin in early ON loss in postacute optic neuritis.
    Klistorner A; Arvind H; Nguyen T; Garrick R; Paine M; Graham S; O'Day J; Grigg J; Billson F; Yiannikas C
    Ann Neurol; 2008 Sep; 64(3):325-31. PubMed ID: 18825673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis.
    Diem R; Sättler MB; Merkler D; Demmer I; Maier K; Stadelmann C; Ehrenreich H; Bähr M
    Brain; 2005 Feb; 128(Pt 2):375-85. PubMed ID: 15601662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of murine experimental autoimmune optic neuritis by mature dendritic cells transfected with calcitonin gene-related Peptide gene.
    Matsuda R; Kezuka T; Nishiyama C; Usui Y; Matsunaga Y; Okunuki Y; Yamakawa N; Ogawa H; Okumura K; Goto H
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5475-85. PubMed ID: 22807299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring experimental autoimmune optic neuritis using multimodal imaging.
    Manogaran P; Walker-Egger C; Samardzija M; Waschkies C; Grimm C; Rudin M; Schippling S
    Neuroimage; 2018 Jul; 175():327-339. PubMed ID: 29627590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the blood-brain barrier in experimental optic neuritis: immunocytochemical co-localization of H2O2 and extravasated serum albumin.
    Guy J; McGorray S; Fitzsimmons J; Beck B; Rao NA
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1114-23. PubMed ID: 8125722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADH-dehydrogenase type-2 suppresses irreversible visual loss and neurodegeneration in the EAE animal model of MS.
    Talla V; Yu H; Chou TH; Porciatti V; Chiodo V; Boye SL; Hauswirth WW; Lewin AS; Guy J
    Mol Ther; 2013 Oct; 21(10):1876-88. PubMed ID: 23752309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.